AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Beam Therapeutics Inc. Director's Dealing 2021

Feb 1, 2021

31533_dirs_2021-02-01_6b90274f-bc8c-48cf-ac61-1f10ebeaa9d6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beam Therapeutics Inc. (BEAM)
CIK: 0001745999
Period of Report: 2021-01-28

Reporting Person: FMR LLC (10% Owner, See Remark 1)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-28	Common Stock	J	356673	—	Acquired	713347	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6971912	Indirect

Footnotes

F1: Impresa Fund III Limited Partnership (IFLP); whose holdings are subject to reporting by the undersigned, received a distribution without payment of consideration, of 356,673 Beam Therapeutics Inc. shares.